Screener
Gyre Therapeutics, Inc. GYRE Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Gyre Therapeutics, Inc.’s reported figures.
The source filing: Gyre Therapeutics, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 5:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-340448
FAQ
- What is Gyre Therapeutics, Inc.'s gross profit?
- Gyre Therapeutics, Inc. (GYRE) reported gross profit of $26.9M in Q2 2026.
- How has Gyre Therapeutics, Inc.'s gross profit changed year-over-year?
- Gyre Therapeutics, Inc.'s gross profit decreased by 5.9% year-over-year, from $28.58M to $26.9M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s gross profit?
- Over 3 years (2022 to 2025), Gyre Therapeutics, Inc.'s gross profit has grown at a 5.4% compound annual growth rate (CAGR), from $97.5M to $114.14M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about Gyre Therapeutics, Inc.'s gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude